Isabel Redondo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Isabel Redondo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alison Potts Bleakman
Eli Lilly and Company, Indianapolis, Indiana, USA
1 shared publication - Axel Dignass
Department of Medicine I Agaplesion Markus Hospital Goethe University Frankfurt am Main Germany
1 shared publication - Cem Kayhan
Eli Lilly and Company, Indianapolis, Indiana, USA
1 shared publication - David T. Rubin
University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL 60637
1 shared publication - Marla C. Dubinsky
Icahn School of Medicine at Mount Sinai, New York, New York, USA
1 shared publication - Remo Panaccione
Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary , Calgary, Alberta
1 shared publication
Latest Publications
- Open Access
- 12 June 2023
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 118 (11) , 1940-1953
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
Bowel urgency (BU), the sudden or immediate need for a bowel movement, is one of the most common and disruptive symptoms experienced by patients with ulcerative colitis (UC). Distinct from the separate symptom of increased stool frequency, BU has a substantial negative impact on quality of life and psychosocial functioning. Among patients with UC, BU is one of the top reasons for treatment dissatisfaction and one of the symptoms patients most want improved. Patients may not discuss BU often due to embarrassment, and healthcare providers may not address the symptom adequately due to the lack of awareness of validated tools and/or knowledge of the importance of assessing BU. The mechanism of BU in UC is multifactorial and includes inflammatory changes in the rectum that may be linked to hypersensitivity and reduced compliance of the rectum. Responsive and reliable patient-reported outcome measures of BU are needed to provide evidence of treatment benefits in clinical trials and facilitate communication in clinical practice. This review discusses the pathophysiology and clinical importance of BU in UC and its impact on the quality of life and psychosocial functioning. Patient-reported outcome measures developed to assess the severity of BU in UC are discussed alongside overviews of treatment options and clinical guidelines. Implications for the future management of UC from the perspective of BU are also explored.
- 12 June 2023
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 118 (11) , 1940-1953
Open AccessBowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
Bowel urgency (BU), the sudden or immediate need for a bowel movement, is one of the most common and disruptive symptoms experienced by patients with ulcerative colitis (UC). Distinct from the separate symptom of increased stool frequency, BU has a substantial negative impact on quality of life and psychosocial functioning. Among patients with UC, BU is one of the top reasons for treatment dissatisfaction and one of the symptoms patients most want improved. Patients may not discuss BU often due to embarrassment, and healthcare providers may not address the symptom adequately due to the lack of awareness of validated tools and/or knowledge of the importance of assessing BU. The mechanism of BU in UC is multifactorial and includes inflammatory changes in the rectum that may be linked to hypersensitivity and reduced compliance of the rectum. Responsive and reliable patient-reported outcome measures of BU are needed to provide evidence of treatment benefits in clinical trials and facilitate communication in clinical practice. This review discusses the pathophysiology and clinical importance of BU in UC and its impact on the quality of life and psychosocial functioning. Patient-reported outcome measures developed to assess the severity of BU in UC are discussed alongside overviews of treatment options and clinical guidelines. Implications for the future management of UC from the perspective of BU are also explored.